Skip to main content
Northwestern University Feinberg School of Medicine
Foundation Relations

Welcome to this non-federal funding opportunities page for biomedical and bioscience research for the Feinberg School of Medicine. Due to the volume of listings, we will list regular opportunities by the month of the deadline. Please click through to get the exact deadline date.

This is a searchable database by career stage and keyword

Career Stage – Please note that if an opportunity is open to more than one category, it will be tagged and found in all eligible career categories. Also, foundations do not consistently consider “early stage” on the same basis. For the purposes of this database, we have listed it with up to six years of experience past postdoc/fellowship. Past that and one should be considered established. Again, if there is a question, we will list an opportunity in both early and established. (For example, if you can have up to ten years experience.)

  • Fellowship Category: Fellowship/post-doc funding opportunities only
  • Early Stage Scientist: up to six years of experience past postdoc/fellowship
  • Established Scientist: more than six years of experience past post-doc/fellowship

Keyword: You’ll be able to search across all listings by any word in any listing.

Our team is in the process of adding funding opportunities to this page every week, so this is not yet a full listing. Please continue to visit this page for more opportunities. Also, if you are in the Feinberg School of Medicine, feel free to contact Michelle Melin-Rogovin for questions about funding opportunities.

Here are some additional websites to search for funding opportunities:

Northwestern University Office of Fellowships - Fellowship Finder

Northwestern University Office of Research Development - Funding Opportunities Powered by Pivot (requires Northwestern NetID login)

Pathways to Science.org (Institute for Broadening Participation)

Duke University - Research Funding Opportunities

UCLA Graduate Programs - Funding Search

The Graduate College at the University of Illinois at Urbana-Champaign - Fellowship Finder

Johns Hopkins University - Postdoctoral Funding Opportunities

Johns Hopkins University - Early Career Funding Opportunities

Stanford University School of Medicine - Calendar of Funding Opportunities

Search by Type

Fellowship
This award is to support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer research (including basic, preclinical, clinical, cancer control, psychosocial, behavioral, epidemiology, health services and health policy research). Awards may be for three years with progressive stipends of $48,000, $50,000, and $52,000 per year, plus a $4,000 per year fellowship allowance (an additional $1,500 is added to the fellowship allowance in the last year to attend the ACS Postdoctoral Fellows Symposium or a domestic scientific meeting). Depending on availability of special endowment funds, the Society annually selects one or more of the top-ranked fellowships to be supplemented above the standard stipend.
More Info  
Fellowship
These fellowships are available to postdoctoral researchers (MD, MD/PhD, PhD, DVM, or equivalent) to provide support for high quality training in disciplines and topics relevant to diabetes, in an environment conducive to beginning a career in diabetes research. Awards are between $47,484-$55,581/year for up to 3 years, plus yearly $5,000 training and $5,000 fringe benefit allowances.
More Info  
Fellowship
These fellowships are available to minority* postdoctoral researchers (MD, MD/PhD, PhD, DVM, or equivalent) who are underrepresented in biomedical research. Fellowships provide support for high quality training in disciplines and topics relevant to diabetes, in an environment conducive to beginning a career in diabetes research. Awards are between $47,484-$55,581/year for up to 3 years, plus yearly $5,000 training and $5,000 fringe benefit allowances. *Eligible racial/ethnic groups are African American or Black, Hispanic/Spanish/Latino, American Indian/Alaskan Native, and Native Hawaiian or Other Pacific Islander.
More Info  
Fellowship
Enhances the integrated research and clinical training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate research group with the mentorship, support, and relevant scientific guidance of a research supervisor. AHA awards are open to the array of academic and health professionals. This includes but is not limited to all academic disciplines (biology, chemistry, mathematics, technology, physics, etc.) and all health-related professions (physicians, nurses, nurse practitioners, pharmacists, dentists, physical and occupational therapists, statisticians, nutritionists, etc.). At the time of award activation, the applicant must hold a post-baccalaureate Ph.D. degree or equivalent, or a doctoral-level clinical degree, such as M.D., D.O., D.V.M., Pharm.D., D.D.S., Dr.Ph, Ph.D. in nursing, public health, or other clinical health science., or equivalent clinical health science doctoral student who seeks research training with a sponsor prior to embarking upon a research career. Awards are for one or two years and awardees may apply for a second two-year award. Maximum of four years of Association postdoctoral fellowship support per individual. Total Award Amount is $63,854 - $150,316.
More Info  
Fellowship
The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 14 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience. Applicants must hold an M.D., D.D.S., D.V.M., or D.O. degree, must not be more than 13 years past their clinical doctorate degree, and may hold a junior faculty appointment (lecturer, instructor, assistant professor-non-tenure track). Applicants with tenure track appointments are not eligible.
More Info  
Fellowship
The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies, and prevention. Damon Runyon Postdoctoral Research Fellowships are granted for a four-year term ($231,000 over 4 years) with second-, third- and fourth- year funding contingent upon satisfactory progress reports. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor.
More Info  
Fellowship
This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers. Damon Runyon-Sohn Pediatric Cancer Fellowships are granted for a four-year term ($231,000 over 4 years) with second-, third- and fourth-year funding contingent upon satisfactory progress reports. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor.
More Info  
Fellowship
The Doris Duke Physician Scientist Fellowship program provides grants to physician scientists at the subspecialty fellowship level who are seeking to conduct additional years of research beyond their subspecialty requirement. The goal is to aid in the transition into a research faculty appointment. The Fellowship consists of $100,000 for annual direct costs plus $10,000 (10 percent) for annual indirect costs for one or two years. The priority of the Physician Scientist Fellowship program is to fund outstanding individuals with excitement for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities for this fellowship based on disease area or research type.
More Info  
Fellowship
Postdoctoral Fellowship Awards are designed to support early-career researchers under the mentorship of an independent investigator. These fellowships are awarded to qualified applicants whose proposed projects investigate hypotheses directly related to Dravet syndrome. Proposals are scored according to NIH guidelines based on the quality of preliminary data, research design, feasibility, investigator's qualifications, and overall impact. Grants are awarded for $50,000 (beginning January 1 of each year), intended to support a full-time research effort with salary and benefits (no indirect costs).
More Info  
Fellowship
FRAXA Fellowships provide $45,000 per year, renewable for a second year of funding (maximum two years), assuming successful progress, and timely submission of a renewal application. Any scientist is eligible for salary support from these awards (not just postdocs), and a supply budget may be included. Given the flexible nature of the new fellowships, a detailed budget is required. Only one position will be supported per project, and the individual should be working at least time on the project. These are significant changes from our previous Fellowships. It is recommended that potential applicants send a brief Letter of Intent to Michael Tranfaglia, MD (mtranfaglia@fraxa.org) well in advance of a formal application. Priority is given to research with a translational or preclinical focus on fragile X, which has potential to lead to improved treatment.
More Info  
Fellowship
The Helen Hay Whitney Foundation supports early postdoctoral research training in all basic biomedical sciences. Candidates who hold, or are in the final stages of obtaining a Ph.D., M.D., or equivalent degree and are seeking beginning postdoctoral training in basic biomedical research are eligible to apply for a fellowship. The Foundation accepts applications from candidates who have no more than one year of postdoctoral research experience at the time of the deadline for submitting the application, and who have received a PhD (or D.Phil. or equivalent) degree no more than two years before the deadline, or an M.D. degree no more than three years before the deadline. Award: $175,500 (Stipend/Research allowance) over three years.
More Info  
Fellowship
The Jane Coffin Childs Memorial Fund for Medical Research was established for the purpose of supporting research into the causes and treatment of cancer. The Fund has taken a broad approach to the study of cell growth and development, emphasizing the study of the basic biology and chemistry of the underlying processes. The current Fellowship stipend levels are Year 1 - $52,000; Year - 2 $52,500 and Year 3 - $53,000. Postdoctoral applicants should have no more than one year of postdoctoral research experience at the time of the deadline for submitting applications; PhD. degree must not have been conferred more than 18 months prior to the deadline date; and MD. degree should not have been conferred more than three years before deadline date of application.
More Info  
Fellowship
Applicants must be a promising investigator with less than 2.5 years of postdoctoral research training. This award encourages you to embark on an academic career involving basic or translational research in hematologic malignancies and/or relevant premalignant conditions under a research sponsor's direction. The proposal must be directly relevant to hematological malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor(s) must be have the appropriate experience to mentor you as you engage in research of direct relevance to blood cancer. The award is for $60,000 per year for three years.
More Info  
Fellowship
Applicants for the Special Fellow Award must be a highly qualified postdoctoral fellow or instructor who's completed a minimum of 2.5 years of postdoctoral research training and is in a mentored research position, continuing a research program of direct relevance to hematological malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor(s) must be have the appropriate experience to mentor you as you engage in blood cancer-relevant research. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period. The award is for $67,000 per year for two or three years.
More Info  
Fellowship
The Life Sciences Research Foundation aims to identify and fund exceptional young scientists at a critical juncture of their training in all areas of basic life sciences, and to provide a high-quality peer-review service to anyone wishing to sponsor a fellow who shares their vision of important research. LSRF does not require a budget; a single type of award is offered - a three-year postdoctoral fellowship. The current award amount is $62,000/year ($186,000 total). Of this, $52,000 is allocated for the fellow's salary/stipend and the remaining $10,000 is a research allowance for the fellow's use.
More Info  
Fellowship
The Lung Cancer Research Foundation's annual pilot grant program provides funding for research focused on the prevention, diagnosis, treatment and cure of lung cancer. The goal of the program is to fund innovative projects across the spectrum of basic, translational, and clinical research. We encourage applications for projects investigating a wide variety of topics including Improving our understanding of lung cancer biology; Prevention and screening for early detection; Identification of new biomarkers and the development of targeted therapies; and Development of more effective and safer therapies. Investigators must be affiliated with a non-profit academic or research institution and must fall into one of the following categories: Students and fellows; Young and mid-career investigators with less than ten years experience since initial faculty appointment; Non-tenure track researchers, staff scientists, and clinicians (any number years of experience). The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).
More Info  
Fellowship
This award supports individuals engaged in multidisciplinary/collaborative research training programs that will extend their credentials in Translational Medicine and Therapeutics. Eligible candidates will have doctoral degrees, e.g., PhD, D.Sc, D.Eng, MD, and seek to further develop and refine their skills and understanding of TMT through post-doctoral training. A key component of TMT involves collaborative programs that span non-clinical and clinical domains, potentially involving multiple laboratories, advisers, and institutions. All applicants must be U.S. citizens or permanent residents. This award is $60,000 per year for up to two years.
More Info  
Early Stage Scientist
The "A" Award is a four-year grant designed for the early independent career scientist who wants to establish a career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of a future commitment to pediatric cancer investigation as well as institutional support for the career development of the investigator are critical components of a successful application. The award is a maximum of $200,000 per year for 4 years, with the possibility of 5th year funding.
More Info  
Early Stage Scientist
The purpose of the grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects should focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations. Two Year Grant Amount: $250,000; up to $125,000 per year may be requested.
More Info  
Early Stage Scientist
The Young Investigator grant is a 3-year award designed to support scientists in the early stages of their research careers, such as postdoctoral or clinical fellows. Outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application. Applicants must have their M.D., Ph.D. or dual M.D., Ph.D. and must not have achieved an appointment higher than Instructor (Assistant Professor level faculty, including Adjuncts at this level, will not be considered). Applicants from accredited clinical fellowship programs are automatically eligible for the duration of their training and during their first three years at the Instructor level. All other applicants must be within five years from the granting of the last doctoral degree. The award amount is up to $150,000 over three years. A maximum of $50,000 in total costs will be awarded to applicants annually. Budget items may include salary, fringe, travel, supplies and small pieces of equipment (less than $5,000).
More Info  
Early Stage Scientist
Each year the Academy recognizes outstanding basic, translational, and clinical research by young dermatology investigators. The purpose of the award is to acknowledge significant research advances in the science and practice of dermatology by those beginning their research careers and who demonstrate the potential to become established, independently-funded investigators in dermatology. Up to two basic/translational researchers and one clinical researcher will be selected. Each recipient will receive a $6,000 prize.
More Info  
Early Stage Scientist
The award provides support of $150,000 for three years for a total of $450,000. This award is for junior investigators interested in an academic career in clinical, basic, or translational neurological research. Recipient must be a neurologist and an AAN member. Recipient must be a neurologist and an AAN member interested in an academic career in neurologic research who completed residency between 5-10 years prior to the start date of the Career Development Award.
More Info  
Early Stage Scientist
This award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000. This award aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies. Recipient must be an AAN member interested in an academic career in neurological research. For the purpose of this scholarship, research is defined as patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurologic disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research. Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
More Info  
Early Stage Scientist
Each award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000. The award aims to recognize the importance of, and encourage young investigators in, good laboratory or preclinical research. Recipient must be an AAN member interested in an academic career in neurological research.
More Info  
Early Stage Scientist
This award is a joint effort between the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American Lung Association. The Allergic Respiratory Diseases Research Award is for $75,000 per year, for up to two years. No more than 75% of the requested budget may be used for an awardee's salary and/or fringe benefits and no more than 30% of the total award budget may be used to fund the purchase of permanent equipment. Grant funds may be used for the salary and fringe benefit costs of personnel other than the Applicant. Grants are subjected to annual review, the second year of support is based on demonstrating satisfactory progress, as well as, the availability of funding from both organizations. At the time of application, the applicant must hold a doctoral degree, have a primary faculty appointment in an allergy/immunology division/section of an academic institution, be undertaking a project related to allergic respiratory disease, and have completed training. Applicants must be independent, self-directed researchers. Applicants may be at any level of research experience but priority will be given to applicants below the rank of associate professor who have not received more than one R award.
More Info  
Early Stage Scientist
The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants are an exciting new funding initiative to stimulate high-risk, high-reward research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice. Applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. At the start of the grant term, applicants must hold an appointment at the rank of assistant or associate professor. The grants provide $400,000 over a two-year period.
More Info  
Early Stage Scientist

American Cancer Society - Research Professor Grant

DEADLINE: Letter of Intent Deadline: August 1; Application Deadline: October 15

The American Cancer Society offers a limited number of grants to mid-career investigators who have made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research. It is expected that these investigators will continue to provide leadership in their research area. Applicants will have attained the rank of full professor. Up to two awards are made annually for a five-year term that can be renewed once. The award of up to $80,000 per year (direct costs only) may be used for salary or research project support.
More Info  
Early Stage Scientist
Fosters the development of clinicians as clinician scientists. Clinician scientists are investigators licensed to provide patient care and trained to conduct research. They pursue research questions across the cancer research continuum of relevance to improving health. This grant provides support for protected time to allow junior faculty who see patients to be mentored and participate in research training to aid their development as independent clinician scientists. Applicants must be full-time and within the first six years of their initial faculty appointment. Awards range from three to five years and for up to $135,000 per year (direct costs), plus 8% allowable indirect costs. A maximum of $10,000 per year for the mentor(s) (regardless of the number of mentors) is included in the $135,000.
More Info  
Early Stage Scientist
Awarded to institutions as block grants to provide seed money for newly independent investigators to initiate research projects. Grants are made for one to three years and average $120,000 per year. These grants are renewable.
More Info  
Early Stage Scientist
Awards to institutions to support physician training in accredited preventive medicine residency programs that provide cancer prevention and control research and practice opportunities. Awards are for four and one-half years in the total amount of $300,000, based on an average of $50,000 per resident training year. These grants are renewable.
More Info  
Early Stage Scientist

American Cancer Society - Research Scholar Grant

DEADLINE: April 1 and October 15

The Research Scholar Grant supports investigator-initiated projects across the cancer research continuum. Independent investigators in the first 6 years of an independent research career or faculty appointment are eligible to apply. Eligibility is extended for 8 years for clinician scientists who remain active in clinical care. Awards are for up to 4 years, for up to $165,000 a year for direct costs, plus 20% allowable indirect costs.
More Info  
Early Stage Scientist
These awards support basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Any level of faculty authorized to work in the United States is eligible to apply. Awards provide up to $115,000 per year for up to three years, including indirect costs.
More Info  
Early Stage Scientist
These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples, and/or data, and offer considerable promise for advancing the cure, prevention, or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Any level of faculty authorized to work in the United States is eligible to apply. Awards provide up to $200,000 per year for up to three years, including indirect costs.
More Info  
Early Stage Scientist
These awards support early investigators as they establish independence as diabetes researchers. Applicants must be full-time independent faculty up to including Assistant Professor or equivalent with less than 10 years of research experience since their terminal degree who do not have previous or current NIH support (R00, R01, U01 or equivalent). Awards are up to $138,000 per year for up to four years including indirect costs. Additionally, applicants can request up to $10,000 per year towards the repayment of the principal on loans for a doctoral degree (MD, PhD, PharmD, DPM or DO).
More Info  
Early Stage Scientist
These awards support early investigators as they establish independence as diabetes researchers. Eligible applicants must be full-time independent faculty up to including Assistant Professor or equivalent from racial/ethnic groups that are underrepresented in biomedical research*, with less than 10 years of research experience since their terminal degree who do not have previous or current NIH support (R00, R01, U01 or equivalent). Awards are up to $138,000 per year for up to four years including indirect costs. Additionally, applicants can request up to $10,000 per year towards the repayment of the principal on loans for a doctoral degree (MD, PhD, PharmD, DPM or DO). *Eligible racial/ethnic groups are African American or Black, Hispanic/Spanish/Latino, American Indian/Alaskan Native, and Native Hawaiian or Other Pacific Islander.
More Info  
Early Stage Scientist
Supports highly promising healthcare and academic professionals, in the early years of one's first professional appointment, to explore innovative questions or pilot studies that will provide preliminary data and training necessary to assure the applicant's future success as a research scientist in the field of cardiovascular and stroke research. The award will develop the research skills to support and greatly enhance the awardee's chances to obtain and retain a high quality cardiovascular and/or stroke career position. Research broadly related to cardiovascular function and disease and stroke, or to related clinical, translational, behavioral, population or basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts. This award is for $77,000 per year, including 10% institutional indirect costs, for a total of $231,000.
More Info  
Early Stage Scientist

American Heart Association - Collaborative Sciences Award

DEADLINE: LOI Deadline: October 8; Application Deadline: January 30

To foster innovative, new collaborative approaches to research projects which propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co- principal investigators and their respective disciplines. The combination and integration of studies may be inclusive of basic, clinical, population and/or translational research. Applications by existing collaborators are permitted, provided that the proposal is for a new idea or new approach that has not been funded before. Projects must include at least one Co-PI from a field outside cardiovascular disease and stroke. This award is also intended to foster collaboration between established and early- or mid-career investigators. Awards are for a three-year period, $250,000 annually for a total of $750,000.
More Info  
Early Stage Scientist
The Innovative Project Award supports highly innovative, high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular or stroke research. Research deemed innovative that may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities is desired. The Innovative Project Award promotes unexplored ideas; therefore, preliminary data is not accepted as part of the proposal, however, a solid rationale for the work must be provided. The candidate must hold a post-baccalaureate Ph.D. degree or equivalent, or a doctoral-level clinical degree, such as M.D., D.O., D.V.M., Pharm.D., or Ph.D. in nursing, public health, or other clinical health science. This program places no limit on eligibility based on career stage, academic rank or discipline. The award is for two years, $100,000 per year, including 10 percent indirect costs, for a total award of $200,000.
More Info  
Early Stage Scientist
This award supports highly innovative, high-impact projects that build on work in progress that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research. Clinical, translational, population, and basic scientists are encouraged to apply. The extent to which the focus of the project is related to CVD and/or stroke is an important factor that will be considered. The candidate must hold a post-baccalaureate Ph.D. degree or equivalent, or a doctoral-level clinical degree, such as M.D., D.O., D.V.M., Pharm.D., or Ph.D. in nursing, public health, or other clinical health science. This program places no limit on eligibility based on career stage, academic rank or discipline. The award is $100,000 per year for 3 years ($300,000 total), including 10 percent indirect costs.
More Info  
Early Stage Scientist
This award is a joint effort between the American Lung Association and the American Academy of Allergy, Asthma & Immunology (AAAAI). The Allergic Respiratory Diseases Research Award is for $75,000 per year, for up to two years. No more than 75% of the requested budget may be used for an awardee's salary and/or fringe benefits and no more than 30% of the total award budget may be used to fund the purchase of permanent equipment. Grant funds may be used for the salary and fringe benefit costs of personnel other than the Applicant. Grants are subjected to annual review, the second year of support is based on demonstrating satisfactory progress, as well as, the availability of funding from both organizations. At the time of application, the applicant must hold a doctoral degree, have a primary faculty appointment in an allergy/immunology division/section of an academic institution, be undertaking a project related to allergic respiratory disease, and have completed training. Applicants must be independent, self-directed researchers. Applicants may be at any level of research experience but priority will be given to applicants below the rank of associate professor who have not received more than one R award.
More Info  
Early Stage Scientist

American Lung Association - Lung Cancer Discovery Award

DEADLINE: LOI Deadline: October 3; Application Deadline: December 13

The Lung Cancer Discovery Award is for highly meritorious research projects with the potential to: significantly improve and transform diagnostic and therapeutic paradigms; foster innovation, use novel approaches; and/or accelerate progress in lung cancer research that improves patient care and helps save lives. This award is $100,000 per year for up to two years. The objective of the award is to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. At the time of application, an applicant must hold a doctoral degree, have a faculty appointment at an academic institution (including research institutions not formally associated with a university), and have completed a training fellowship. Applicants may be at any level of research experience and must be independent, self-directed researchers.
More Info  
Early Stage Scientist
The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 14 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience. Applicants must hold an M.D., D.D.S., D.V.M., or D.O. degree, must not be more than 13 years past their clinical doctorate degree, and may hold a junior faculty appointment (lecturer, instructor, assistant professor-non-tenure track). Applicants with tenure track appointments are not eligible.
More Info  
Early Stage Scientist
Each applicant must be nominated by their institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation. The Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The $600,000 award will be for a period of three years. Funding in the amount of $200,000 will be allocated to the awardee's institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator's stipend and/or fringe benefits (up to $130,000 annually), salaries for professional and technical personnel, special equipment, supplies, and other miscellaneous items required to conduct the proposed research.
More Info  
Early Stage Scientist
The Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. The Stage 1 award is for two years, $200,000 per year ($400,000 total) with the opportunity for up to two additional years of Stage 2 funding (up to four years total for $800,000).
More Info  
Early Stage Scientist
The Damon Runyon Cancer Research Foundation wishes to encourage more physicians to pursue research careers and has established a program designed to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training. This award will provide a funding source that will enable these individuals to pursue research intensively (at least 80% effort) for up to four years, while, if they wish to maintain their clinical skills, continuing to be clinically active (no more than 20% effort). The award is $460,000 over a period of four years. Funding will be allocated to the awardee's institution each year for the support of the scientist. Funds are to be used for stipend and/or research expenses.
More Info  
Early Stage Scientist

Doris Duke Charitable Foundation - Clinical Scientist Development Award

DEADLINE: Anticipated Deadline for Pre-Proposals: Mid-November

The Doris Duke Clinical Scientist Development Award provides grants to early-career physician scientists to facilitate their transition to independent clinical research careers. The Award consists of $150,000 annual direct costs for three years (total $450,000 total). The priority of the CSDA program is to fund outstanding individuals with potential for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities based on disease area or research type. After submitting a pre-proposal, the Foundation determines who to invite to submit a full proposal.
More Info  
Early Stage Scientist
Clinician-Researcher Awards support hypothesis-driven clinical research projects that have significant potential to advance our understanding of Dravet syndrome; slow or halt the of progression of the disease, characteristics, or comorbidities of the disease; and/or reduce mortality. The projects must be patient-oriented, with the investigator directly interacting with human subjects/patients. This includes studies such as therapeutic interventions or support/extension of existing clinical trials. Award funds of $150,000 for two years ($75,000 per year) are made to the affiliated institution in four payments, the second of which is dependent on IRB approval if not required for the first portion of the funding period.
More Info  
Early Stage Scientist

A Kids’ Brain Tumor Cure Foundation - Research Grant

DEADLINE: Open now – LOI’s are submitted throughout the entire year

The number one priority of A Kids' Brain Tumor Cure Foundation is to act as a catalyst for researchers world-wide to turn their attention to the area of pediatric low grade glioma brain tumor research and to award research grants for the most promising programs and studies. Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of PLGA tumors will be considered. Investigators in the early years of their careers are encouraged to apply. Funding ranges from $100,000 to $500,000 depending on the project scope and duration.
More Info  
Early Stage Scientist
The Scholar award supports talented blood cancer researchers in the early phase of their careers. You must be a highly qualified investigator who has shown a capacity for independent, sustained, original investigation in the field of hematologic malignancies. You should hold an independent faculty-level position and should have obtained substantial support for your research from a national agency. The funding amount is $120,000 per year. Applicants can apply for $600,000 total for the five-year award (inclusive of indirect costs). Applicants must have started their first independent position no less than two years but no more than 8 years before the time of review.
More Info  
Early Stage Scientist
Scholar in Clinical Research Award applicants must be highly qualified investigators who hold an independent faculty-level appointment and who are conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies. The research should be related to their clinical activities, and must involve patients. Scholar in Clinical Research applicants must: have a Sponsor who will attest to institutional support such as a department head, chief of service, or program chair for the applicant; be an independent investigator of at least an Assistant Professor position or equivalent including any permanent, independent clinical faculty who are not on a laboratory-based, tenure-track career path; have clinical training in blood cancer; have adequate funding to support the proposed research; have started their first independent position within 10 years of the time of review; have protected time for research after the funding start date in the range of 20-40% (if an investigator is more laboratory-based than clinic-based, they cannot apply for this award and should consider the Scholar award); be performing clinical research involving patients (generally clinical trials), which is related to their clinical duties. The award is $125,000 per year for five years ($625,000 total).
More Info  
Early Stage Scientist
The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to offer a new research grant opportunity focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies. Proposals on a variety of topics including the following are encouraged: Patterns of real-world versus pre-approval patient side-effect experiences; Defining and understanding tolerability (including late toxicities and patient reported outcomes); Role of diverse, multi-disciplinary teams (including pharmacists, dieticians, caregivers, etc.) and coordination of care in managing and monitoring therapy; Real-time symptom monitoring; and Implementation science approaches to improving care delivery. Pfizer and LCRF will support up to three innovative health services research projects focused on the improved management of treatment toxicities from targeted therapies in NSCLC patients. Specifically, up to $350,000 will be provided over a period of two years.
More Info  
Early Stage Scientist
The Lung Cancer Research Foundation's annual pilot grant program provides funding for research focused on the prevention, diagnosis, treatment and cure of lung cancer. The goal of the program is to fund innovative projects across the spectrum of basic, translational, and clinical research. We encourage applications for projects investigating a wide variety of topics including Improving our understanding of lung cancer biology; Prevention and screening for early detection; Identification of new biomarkers and the development of targeted therapies; and Development of more effective and safer therapies. Investigators must be affiliated with a non-profit academic or research institution and must fall into one of the following categories: Students and fellows; Young and mid-career investigators with less than ten years experience since initial faculty appointment; Non-tenure track researchers, staff scientists, and clinicians (any number years of experience). The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).
More Info  
Early Stage Scientist
NBF awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management. Research content areas eligible for the grant program include Immunology, Hematology, Immunohematology, Infectious Diseases, Cellular Therapies, and Patient Blood Management. The grant maximum award of $75,000 must be used exclusively for research. An applicant must be a doctor (MD or PhD), medical technologist, transfusion medicine or cellular therapies professional. An early-stage investigator is a new investigator who has completed a terminal research degree or medical residency whichever date is later within the past 10 years of the grant application deadline and has not yet been awarded a substantial research grant (i.e. NIH R01).
More Info  
Early Stage Scientist
These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis. The qualifications for a candidate for the Brian D. Novis Junior Research Award include: completed postdoctoral studies or clinical fellowships no later than August 1 of the application year; ability to devote a minimum of 50% of his or her time to the research project during the Award year; ability to provide a completed application with evidence of a meritorious research project. The awards are $50,000 for one year.
More Info  
Early Stage Scientist

Parkinson's Foundation - Stanley Fahn Junior Faculty Award

DEADLINE: Anticipated LOI Deadline: Mid-November

The award acts as a bridge to ensure promising early career scientists stay in the Parkinson's research field, helping us solve, treat and end the disease. In conjunction with their institution's commitment, the award gives junior investigators the support they need to develop their own independent funding source (such as an NIH R01 award) and stay in the PD research field. Each award provides $300,000 in total costs. The award funds for three years -- subject to annual progress reviews.
More Info  
Early Stage Scientist
The grant provides funding of $100,000 for one year. The aim of these grants is to assist individuals beginning independent research careers in health outcomes at the faculty level. Health Outcomes research spans a broad spectrum of issues related to health-care delivery, from studies evaluating effectiveness of a pharmaceutical intervention, to the impact of reimbursement policies on outcomes of care. Applicants holding academic rank of instructor or assistant professor, and investigators at the doctoral level with equivalent positions, are eligible to apply.
More Info  
Early Stage Scientist
The Bridge to Independence Award program promotes talented early-career scientists by facilitating their transition to research independence and providing grant funding at the start of their professorships. Awards are aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the upcoming academic year. Awardees will receive a commitment of $495,000 over three years, activated upon assumption of a tenure-track professorship.
More Info  
Established Scientist
The purpose of the grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects should focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations. Two Year Grant Amount: $250,000; up to $125,000 per year may be requested.
More Info  
Established Scientist
These awards will support investigators pursuing research studies in human populations using epidemiological approaches aimed at improving our understanding of childhood cancer. This grant mechanism is designed to support hypothesis-driven research that focuses on the epidemiology, early detection and prevention of childhood cancer or comparative effectiveness and outcomes research related to detection, prevention, and treatment. Applicants should be at the Assistant, Associate or Full Professor level and have a history of formal training in disciplines that are relevant to the proposed research or a track record of conducting similar epidemiological or cancer research, including peer-reviewed publications and funding, that demonstrates the project can be accomplished by the investigator. Funding for two years, maximum of $100,000 per year, may be requested for direct costs.
More Info  
Established Scientist
Innovation Grants are designed as seed funding for researchers with a novel approach to pediatric oncology scientific investigation. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator's prior research but for which a strong case is made for the potential impact on childhood cancers. Innovation Grants will support research proposals to be carried out by investigators who are already established, have a recent track record of peer-reviewed publications and evidence of successfully competing for extramural funding. The grant is for two years up to $125,000 per year for direct costs only. Applicants must have a faculty appointment at an academic institution. Track record of publication and funding productivity in the last 5 years must demonstrate that the project can be accomplished by the investigator(s).
More Info  
Established Scientist
The purpose of the Reach Grant is to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. The goal of this award is to support selected late translational studies. Preference will be given to those research projects which, if funded, will likely result in the initiation of a clinical trial two to three years from the start of the project. Applicants may be Assistant, Associate or Professor level investigators who demonstrate a track record of discovery, investigation and external funding and who have a demonstrated track record of pediatric cancer research with experience in translational research. A maximum of $125,000 in total costs may be requested per year and a maximum of two years of funding may be requested.
More Info  
Established Scientist
Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. Preference will be given to those working in solid tumors, orphan tumors or pediatric tumors, and to research not previously funded, thus highly innovative proposals. The award provides up to a maximum of $500,000 distributed over 2-3 years, inclusive of a maximum of 10% indirect costs. Candidates for the Investigator's Award in Cell and Gene Therapy for Cancer must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty. The investigator must be conducting original research as an independent faculty member.
More Info  
Established Scientist

Alzheimer's Drug Discovery Foundation - Drug Discovery Program

DEADLINE: LOI Deadlines January, April, July, October

The Alzheimer's Drug Discovery Foundation (ADDF) has long recognized the need to bridge the translational funding gap between early-stage drug discovery and clinical development for Alzheimer's disease, related dementias, and cognitive aging by supporting promising therapeutic approaches. The Drug Discovery RFP supports novel drug programs aiming to advance novel lead molecules to the clinical candidate selection stage; and repurposed/repositioned programs aiming to build preclinical evidence in relevant animal models for repurposed drugs (existing drugs that are approved for other diseases and conditions) and repositioned drugs (existing drugs that have entered clinical trials for other indications and have not yet been approved). Funding is open to researchers and clinicians worldwide at academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged. Funding is $150,000-$600,000 based on stage and scope of research and is typically for one year with potential for follow-on funding. Multi-year proposals can be considered.
More Info  
Established Scientist

American Cancer Society - Research Professor Grant

DEADLINE: Letter of Intent Deadline: August 1; Application Deadline: October 15

The American Cancer Society offers a limited number of grants to mid-career investigators who have made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research. It is expected that these investigators will continue to provide leadership in their research area. Applicants will have attained the rank of full professor. Up to two awards are made annually for a five-year term that can be renewed once. The award of up to $80,000 per year (direct costs only) may be used for salary or research project support.
More Info  
Established Scientist

American Cancer Society - Research Professor Grant

DEADLINE: Letter of Intent Deadline: February 1; Application Deadline: April 1

The American Cancer Society offers a limited number of grants to mid-career investigators who have made seminal contributions that have changed the direction of basic cancer research. It is expected that these investigators will continue to provide leadership in their research area. Applicants will have attained the rank of full professor. Up to two awards are made annually for a five-year term that can be renewed once. The award of up to $80,000 per year (direct costs only) may be used for salary or research project support.
More Info  
Established Scientist
These awards support basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Any level of faculty authorized to work in the United States is eligible to apply. Awards provide up to $115,000 per year for up to three years, including indirect costs.
More Info  
Established Scientist
These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples, and/or data, and offer considerable promise for advancing the cure, prevention, or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Any level of faculty authorized to work in the United States is eligible to apply. Awards provide up to $200,000 per year for up to three years, including indirect costs.
More Info  
Established Scientist

American Heart Association - Collaborative Sciences Award

DEADLINE: LOI Deadline: October 8; Application Deadline: January 30

To foster innovative, new collaborative approaches to research projects which propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co- principal investigators and their respective disciplines. The combination and integration of studies may be inclusive of basic, clinical, population and/or translational research. Applications by existing collaborators are permitted, provided that the proposal is for a new idea or new approach that has not been funded before. Projects must include at least one Co-PI from a field outside cardiovascular disease and stroke. This award is also intended to foster collaboration between established and early- or mid-career investigators. Awards are for a three-year period, $250,000 annually for a total of $750,000.
More Info  
Established Scientist

American Heart Association - Established Investigator Award

DEADLINE: LOI Deadline: October 10; Application Deadline: January 15

The Established Investigator Award supports mid-career investigators (typically at associate professor level) with unusual promise and established records of accomplishments; candidates should have a demonstrated commitment to cardiovascular or cerebrovascular science disciplines, as indicated by prior publication history and scientific accomplishments. The applicant should have an M.D., Ph.D., D.O. or equivalent doctoral degree, be in a faculty/staff scientist position or equivalent (at the time of award activation, the awardee must be at the level of associate professor/staff scientist or equivalent) and have current national-level funding as a principal investigator (or co-PI) on an R01 grant or its equivalent. Awards are for five years, non-renewable, for $80,000 per year, including 10 percent indirect costs, for a total award of $400,000.
More Info  
Established Scientist
The Innovative Project Award supports highly innovative, high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular or stroke research. Research deemed innovative that may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities is desired. The Innovative Project Award promotes unexplored ideas; therefore, preliminary data is not accepted as part of the proposal, however, a solid rationale for the work must be provided. The candidate must hold a post-baccalaureate Ph.D. degree or equivalent, or a doctoral-level clinical degree, such as M.D., D.O., D.V.M., Pharm.D., or Ph.D. in nursing, public health, or other clinical health science. This program places no limit on eligibility based on career stage, academic rank or discipline. The award is for two years, $100,000 per year, including 10 percent indirect costs, for a total award of $200,000.
More Info  
Established Scientist

American Heart Association - Merit Award

DEADLINE: LOI Deadline: July 11

This award will support exceptional scientists with established track records of success, who propose novel approaches to major research challenges in the areas of CV and stroke that have the potential to produce unusually high impact. This competition will enable AHA to further develop and strengthen the community of CV and stroke researchers and bring innovative approaches to basic, clinical, population and translational studies through funding a variety of disciplines. Applications are encouraged from all basic disciplines as well as epidemiological, behavioral, community and clinical investigations that bear on cardiovascular and stroke problems and must describe the capacity of the investigator's work to transform fundamental scientific understanding, clinical practice, and/or public health policy. Applicant requirements: Ph.D. and/or M.D. (or the equivalent), tenured or tenure-track professor, principal investigator on multiple active, national peer-reviewed research awards of at least three years duration, such as an NIH R01 grant, at the time of application. Awards are for a five-year period, $200,000 annually for a total of $1,000,000.
More Info  
Established Scientist
This award supports highly innovative, high-impact projects that build on work in progress that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research. Clinical, translational, population, and basic scientists are encouraged to apply. The extent to which the focus of the project is related to CVD and/or stroke is an important factor that will be considered. The candidate must hold a post-baccalaureate Ph.D. degree or equivalent, or a doctoral-level clinical degree, such as M.D., D.O., D.V.M., Pharm.D., or Ph.D. in nursing, public health, or other clinical health science. This program places no limit on eligibility based on career stage, academic rank or discipline. The award is $100,000 per year for 3 years ($300,000 total), including 10 percent indirect costs.
More Info  
Established Scientist

American Lung Association - Lung Cancer Discovery Award

DEADLINE: LOI Deadline: October 3; Application Deadline: December 13

The Lung Cancer Discovery Award is for highly meritorious research projects with the potential to: significantly improve and transform diagnostic and therapeutic paradigms; foster innovation, use novel approaches; and/or accelerate progress in lung cancer research that improves patient care and helps save lives. This award is $100,000 per year for up to two years. The objective of the award is to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. At the time of application, an applicant must hold a doctoral degree, have a faculty appointment at an academic institution (including research institutions not formally associated with a university), and have completed a training fellowship. Applicants may be at any level of research experience and must be independent, self-directed researchers.
More Info  
Established Scientist
The APDA Centers for Advanced Research are a core part of the research programs sponsored by the APDA and serve to accelerate research on treatments and cures for Parkinson disease. An Advanced Center should be led by a director with an international reputation and a track record of outstanding research in Parkinson disease. The Center should be located at an institution with a substantial existing programs of Parkinson patient care as well as clinical and translational research relevant to Parkinson disease. The Center should involve a multidisciplinary team of scientific and clinical investigators well positioned to engage in innovative, high impact PD research. The Centers serve as an educational resource for the Parkinson community, and provide training for physicians, postdoctoral fellows, graduate students, medical students, and health care professionals. Integration with existing APDA programs, including research programs, Information and Referral Centers, and regional APDA Chapters is encouraged. Support for the Centers is an annual award of $100,000.
More Info  
Established Scientist
Clinician-Researcher Awards support hypothesis-driven clinical research projects that have significant potential to advance our understanding of Dravet syndrome; slow or halt the of progression of the disease, characteristics, or comorbidities of the disease; and/or reduce mortality. The projects must be patient-oriented, with the investigator directly interacting with human subjects/patients. This includes studies such as therapeutic interventions or support/extension of existing clinical trials. Award funds of $150,000 for two years ($75,000 per year) are made to the affiliated institution in four payments, the second of which is dependent on IRB approval if not required for the first portion of the funding period.
More Info  
Established Scientist
Research Grant Awards are intended for established, experienced, independent investigators affiliated with a research or academic institution whose proposed projects investigate hypotheses directly related to Dravet syndrome. Proposals are scored according to NIH guidelines based on the quality of preliminary data, research design, feasibility, investigator's qualifications, and overall impact. Grants are awarded for $150,000 over 2 years (beginning January 1 of each year), with indirect costs not to exceed 10% of the award. Our 2019 priority areas include: Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to Dravet syndrome, facilitating the continued investigation of disease-modifying or preventative strategies; Research that will encourage the development of novel therapies to prevent onset or halt the progression of the Dravet syndrome; and Research focused on new, effective treatments for Dravet syndrome and/or its comorbidities.
More Info  
Established Scientist
Scholar in Clinical Research Award applicants must be highly qualified investigators who hold an independent faculty-level appointment and who are conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies. The research should be related to their clinical activities, and must involve patients. Scholar in Clinical Research applicants must: have a Sponsor who will attest to institutional support such as a department head, chief of service, or program chair for the applicant; be an independent investigator of at least an Assistant Professor position or equivalent including any permanent, independent clinical faculty who are not on a laboratory-based, tenure-track career path; have clinical training in blood cancer; have adequate funding to support the proposed research; have started their first independent position within 10 years of the time of review; have protected time for research after the funding start date in the range of 20-40% (if an investigator is more laboratory-based than clinic-based, they cannot apply for this award and should consider the Scholar award); be performing clinical research involving patients (generally clinical trials), which is related to their clinical duties. The award is $125,000 per year for five years ($625,000 total).
More Info  
Established Scientist
The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to offer a new research grant opportunity focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies. Proposals on a variety of topics including the following are encouraged: Patterns of real-world versus pre-approval patient side-effect experiences; Defining and understanding tolerability (including late toxicities and patient reported outcomes); Role of diverse, multi-disciplinary teams (including pharmacists, dieticians, caregivers, etc.) and coordination of care in managing and monitoring therapy; Real-time symptom monitoring; and Implementation science approaches to improving care delivery. Pfizer and LCRF will support up to three innovative health services research projects focused on the improved management of treatment toxicities from targeted therapies in NSCLC patients. Specifically, up to $350,000 will be provided over a period of two years.
More Info  
Established Scientist
The Lung Cancer Research Foundation's annual pilot grant program provides funding for research focused on the prevention, diagnosis, treatment and cure of lung cancer. The goal of the program is to fund innovative projects across the spectrum of basic, translational, and clinical research. We encourage applications for projects investigating a wide variety of topics including Improving our understanding of lung cancer biology; Prevention and screening for early detection; Identification of new biomarkers and the development of targeted therapies; and Development of more effective and safer therapies. Investigators must be affiliated with a non-profit academic or research institution and must fall into one of the following categories: Students and fellows; Young and mid-career investigators with less than ten years experience since initial faculty appointment; Non-tenure track researchers, staff scientists, and clinicians (any number years of experience). The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).
More Info  
Established Scientist
These awards are targeted to established investigators with a track record in myeloma or related disorders, and are designed for projects which represent a different focus, direction, or area of research from those in which they are currently funded. In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies. The awards are $80,000 for one year.
More Info  
Back to top